Birdman, do you actually ever read any of the documents you link to?
You seem to have missed this bit:
"As the company transforms into a service business, we expect Cochlear to be bigger and better ten years from now. The problem is the price. At a forward price-earnings ratio of 36 you’re already paying for that growth. There’s little room for error, and the soon-to-be-released Advanced Bionics model risks derailing Mr Market's optimism if its a hit. This is a great business with an unattractive price. You’ll find better opportunities on our Buy list."
I agree with their analysis in that a P/E of 36 is not sustainable
Birdman, do you actually ever read any of the documents you link...
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$317.00 |
Change
4.170(1.33%) |
Mkt cap ! $20.73B | |||
| Open | High | Low | Value | Volume |
| $314.28 | $318.91 | $313.71 | $43.40M | 137.0K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 6 | 324 | $317.00 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $317.18 | 55 | 1 |
View Market Depth
| Last trade - 16.10pm 28/07/2025 (20 minute delay) ? |
| COH (ASX) Chart |